A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience-Reference-Cited by-同舟云学术

A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience

Published:2022 Issue:10 Volume:69 Page:1201-1209
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Murakami Masatoshi¹,Fujimori Nao¹,Matsumoto Kazuhide¹,Ohno Akihisa¹,Teramatsu Katsuhito¹,Takamatsu Yu¹,Takeno Ayumu¹,Ueda Keijiro¹,Oono Takamasa¹,Ito Tetsuhide²,Ogawa Yoshihiro¹

Affiliation:

1. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan

2. Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, Fukuoka 814-0001, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/10/69_EJ22-0111/_pdf

Reference25 articles.

1. 1 Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, et al. (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26: 3063–3072.

2. 2 Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, et al. (2015) Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50: 58–64.

3. 3 Dasari A, Shen C, Halperin D, Zhao B, Zhou S, et al. (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3: 1335–1342.

4. 4 Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, et al. (2021) Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors. Ann Surg 274: 1051–1057.

5. 5 Fujimori N, Miki M, Lee L, Matsumoto K, Takamatsu Y, et al. (2020) Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years. Pancreatology 20: 709–715.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms;Scientific Reports;2024-08-09

2. All you need to know about VIPoma: Review on the latest studies;La Presse Médicale;2024-06

3. Longterm outcome of rare functioning pancreatic neuroendocrine neoplasms;2024-03-05

4. Management of pancreatic neuroendocrine neoplasms in Japan's rapidly aging society;Suizo;2024-02-29

5. Two cases of pancreatic neuroendocrine tumors with ectopic ACTH syndrome during their disease course;Clinical Journal of Gastroenterology;2024-01-20